Skip to main content
Livermore
Livermore
ZHEN

Ascendis Pharma A/S

ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612042

In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Ascendis Pharma A/S changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ASND: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1852189+6
Shares60.3M725.8K60.8M+1.26M (+2.1%)
Value$7.59B$91.4M$9.19B+$1.69B (+22.6%)

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (39)

Institutions that held Ascendis Pharma A/S at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ASND in Q1 2024
InstitutionSharesValue% of portfolio
Summit Partners Public Asset Management, LLC225,111$34.0M1.63%
Two Sigma Investments, LP210,325$31.8M0.08%
Two Sigma Advisers, LP163,400$24.7M0.06%
Victory Capital Management Inc134,564$20.3M0.02%
Farallon Capital Management, L.L.C.109,000$16.5M0.10%
Driehaus Capital Management LLC100,320$15.2M0.15%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.86,202$13.0M0.03%
Atika Capital Management LLC48,500$7.33M0.82%
Cinctive Capital Management LP48,383$7.31M0.38%
Polar Asset Management Partners Inc.44,089$6.66M0.18%
Marshall Wace, LLP25,084$3.79M0.01%
Artia Global Partners LP15,894$2.40M0.59%
Nan Fung Group Holdings Ltd13,600$2.06M1.90%
Superstring Capital Management LP12,754$1.93M1.27%
Caption Management, LLC9,426$1.42M0.16%
Gsa Capital Partners LLP6,564$992.0K0.08%
Engineers Gate Manager LP6,476$979.0K0.03%
AXS Investments LLC6,000$907.0K0.22%
Aigen Investment Management, LP5,910$893.4K0.19%
FORA Capital, LLC4,649$702.8K0.06%
Torno Capital, LLC4,500$680.3K0.15%
Aquatic Capital Management LLC4,300$650.0K0.02%
Soros Fund Management LLCSuperinvestorSoros Fund Management3,432$518.8K0.01%
SG Americas Securities, LLC1,903$288.0K0.00%
Pinpoint Asset Management Ltd1,698$256.7K0.04%
Mariner, LLC1,686$254.9K0.00%
Moody Aldrich Partners LLC1,523$230.2K0.04%
CM Wealth Advisors LLC1,674$227.6K0.07%
HC Advisors, LLC1,479$223.6K0.11%
Icapital Wealth LLC1,451$219.3K0.13%
Algert Global LLC1,410$213.2K0.01%
Quarry LP700$105.8K0.04%
Cutler Group LP440$66.0K0.03%
Private Ocean, LLC241$36.4K0.00%
TD Waterhouse Canada Inc.164$24.0K0.00%
Farther Finance Advisors, LLC155$23.6K0.00%
Elequin Capital LP50$7.56K0.00%
Hollencrest Capital Management38$5.74K0.00%
Thurston, Springer, Miller, Herd & Titak, Inc.14$2.12K0.00%

Sold out (33)

Institutions that held Ascendis Pharma A/S at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ASND in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Eventide Asset Management, LLC180,857$22.8M
Camber Capital Management LP165,000$20.8M
Perceptive Advisors LLC132,176$16.6M
Tang Capital Management LLC70,000$8.82M
Captrust Financial Advisors28,051$3.53M
Ghost Tree Capital, LLC20,000$2.52M
Affinity Asset Advisors, LLC20,000$2.52M
Rosalind Advisors, Inc.16,800$2.12M
HAP Trading, LLC12,299$1.55M
Raymond James Financial Services Advisors, Inc.8,224$1.04M
Values First Advisors, Inc.7,844$987.9K
Prelude Capital Management, LLC6,500$818.7K
Axq Capital, LP6,300$793.5K
Squarepoint Ops LLC5,881$740.7K
Sequoia Financial Advisors, LLC5,811$731.9K
Group One Trading, L.P.5,808$731.5K
Bayesian Capital Management, LP5,561$700.4K
CenterBook Partners LP5,207$655.8K
GTS Securities LLC4,316$543.6K
Campbell & CO Investment Adviser LLC3,997$503.4K
Capstone Investment Advisors, LLC3,681$463.6K
Scientech Research LLC3,217$405.2K
Maven Securities LTD3,000$377.9K
Fox Run Management, L.L.C.2,986$376.1K
Wedbush Securities Inc2,413$304.0K
Simplex Trading, LLC2,270$285.0K
Camden Capital, LLC2,144$270.0K
Virtu Financial LLC2,002$252.0K
Advisory Services Network, LLC145$18.3K
Headlands Technologies LLC121$15.2K
Cullen/Frost Bankers, Inc.100$12.6K
Able Wealth Management LLC10$1.26K
Sofos Investments, Inc.2$212

Not filed for Q1 2024 yet (2)

Institutions that held Ascendis Pharma A/S at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASND in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Putnam Investments LLC725,651$91.4M
Coppell Advisory Solutions LLC141$13.5K